{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:07:35Z","timestamp":1761664055536,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mehy.2020.109843","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T02:36:08Z","timestamp":1589769368000},"page":"109843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?"],"prefix":"10.1016","volume":"143","author":[{"given":"Anuruddha","family":"Abeygunasekera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saroj","family":"Jayasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.109843_b0005","unstructured":"https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200325-sitrep-65-COVID-19.pdf?sfvrsn=2b74edd8_2 accessed 26 March 2020."},{"issue":"3","key":"10.1016\/j.mehy.2020.109843_b0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.mehy.2020.109843_b0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses \u2013 drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.mehy.2020.109843_b0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.mehy.2020.109843_b0025","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.0c00052","article-title":"Broad spectrum antiviral agent niclosamide and its therapeutic potential","author":"Xu","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.mehy.2020.109843_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40779-020-00240-0","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak \u2013 an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Military Med Res"},{"key":"10.1016\/j.mehy.2020.109843_b0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jmv.25709","article-title":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV","volume":"92","author":"Liu","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.mehy.2020.109843_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0819-2","article-title":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19","author":"Thevarajan","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2020.109843_b0045","article-title":"Research progress on the mechanism of cytokine storm induced by new coronavirus pneumonia and related immunotherapy","volume":"36","author":"Cheng","year":"2020","journal-title":"Chinese J Burns"},{"key":"10.1016\/j.mehy.2020.109843_b0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.109843_b0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.mehy.2020.109843_b0060","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1084\/jem.20150632","article-title":"Critical role of phospholipase A2group IID in age-related susceptibility to severe acute respiratory syndrome\u2013CoV infection","volume":"212","author":"Vijay","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2020.109843_b0065","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1172\/JCI59777","article-title":"Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice","volume":"121","author":"Zhao","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.mehy.2020.109843_b0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejphar.2014.03.046","article-title":"Anti-inflammatory effects of diethylcarbamazine: a review","volume":"734","author":"Peixoto","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2020.109843_b0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/08923973.2011.630008","article-title":"Immunomodulatory activity of diethyl carbamazine on humoral cellular cytokine response and respiratory burst in BALB\/c mice","volume":"34","author":"Medina-De la Garza","year":"2012","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"5","key":"10.1016\/j.mehy.2020.109843_b0080","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.lfs.2006.01.022","article-title":"Effect of combination of nitric oxide synthase and cyclooxygenase inhibitors on carrageenan-induced pleurisy in rats","volume":"79","author":"Sakaguchi","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.mehy.2020.109843_b0085","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/105120","article-title":"Diethylcarbamazine attenuates the development of carrageenan-induced lung injury in mice","author":"Ribeiro","year":"2014","journal-title":"Mediators Inflam"},{"key":"10.1016\/j.mehy.2020.109843_b0090","unstructured":"Kumara Maduwa Gedera Sagara Ruwan, Thiranagama Prasanga, Sosai Cherine, Abeygunasekera Anuruddha. A case of follicular cystitis treated successfully with diethyl carbamazine. Asian J Urol. https:\/\/ doi.org\/10.1016\/j.ajur.2020.03.003 (Published online first)."},{"issue":"3","key":"10.1016\/j.mehy.2020.109843_b0095","first-page":"97","article-title":"Effect of administration of diethylcarbamazine on murine leukemia virus (Cas-Br-M) infected mice","volume":"33","author":"Kitchen","year":"1990","journal-title":"J Clin Lab Immunol"},{"issue":"5","key":"10.1016\/j.mehy.2020.109843_b0100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jmv.25707","article-title":"Potential interventions for novel coronavirus in China: a systematic review","volume":"92","author":"Zhang","year":"2020","journal-title":"J Med Virol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720305636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720305636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:22:08Z","timestamp":1759692128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720305636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":20,"alternative-id":["S0306987720305636"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109843","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109843"}}